Peng Zhao
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 6
- Epidemiology top 5%
- Adipokines, Inflammation, and Metabolic Diseases 10
- Liver Disease Diagnosis and Treatment 6
- Molecular Biology top 5%
- Metabolism, Diabetes, and Cancer 6
- Immunology top 5%
- Immunotherapy and Immune Responses 7
- Immune Cell Function and Interaction 6
- Biomaterials top 5%
-
- Nanoplatforms for cancer theranostics 8
-
- Neuroinflammation and Neurodegeneration Mechanisms 5
- Co-authors
- Alan R. SaltielJacqueline M. StephensNing GuXiaoli SunZhongji LiaoRohit LoombaMichael KarinMingnan Chen
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Peng Zhao
94 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Cancer Research 513
- Epidemiology 825
- Molecular Biology 1.5k
- Immunology 467
- Biomaterials 287
Countries citing papers authored by Peng Zhao
This map shows the geographic impact of Peng Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Zhao more than expected).
Fields of papers citing papers by Peng Zhao
This network shows the impact of papers produced by Peng Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Zhao. The network helps show where Peng Zhao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peng Zhao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2022 | 9 | |
| 6 | 2022 | 4 | |
| 7 | 2021 | 14 | |
| 8 | 2021 | 7 | |
| 9 | An AMPK–caspase-6 axis controls liver damage in nonalcoholic steatohepatitisbreakdown → | 2020 | 236 |
| 10 | 2020 | 37 | |
| 11 | Effects of triptolide and methotrexate nanosuspensions on left ventricular remodeling in autoimmune myocarditis rats | 2019 | 1 |
| 12 | ER Stress Drives Lipogenesis and Steatohepatitis via Caspase-2 Activation of S1Pbreakdown → | 2018 | 246 |
| 13 | 2017 | 31 | |
| 14 | 2017 | 122 | |
| 15 | 2016 | 32 | |
| 16 | 2016 | 15 | |
| 17 | 2016 | 226 | |
| 18 | 2014 | 80 | |
| 19 | 2014 | 52 | |
| 20 | 2012 | 14 |
About Peng Zhao
Peng Zhao is a scholar working on Cancer Research, Immunology and Complementary and alternative medicine, having authored 97 papers that have together received 3.4k indexed citations. Recurring topics across this work include Adipokines, Inflammation, and Metabolic Diseases (10 papers), Nanoplatforms for cancer theranostics (8 papers), Immunotherapy and Immune Responses (7 papers), Metabolism, Diabetes, and Cancer (6 papers), Immune Cell Function and Interaction (6 papers), Cancer-related molecular mechanisms research (6 papers), Liver Disease Diagnosis and Treatment (6 papers) and Neuroinflammation and Neurodegeneration Mechanisms (5 papers). The work is most often cited by research in Cancer Research (513 citations), Epidemiology (825 citations) and Molecular Biology (1.5k citations). Peng Zhao has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Alan R. Saltiel, Jacqueline M. Stephens, Ning Gu, Xiaoli Sun, Zhongji Liao, Rohit Loomba, Michael Karin, Mingnan Chen, Hao Wu and Shuyun Dong. Their work appears in journals such as Science, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.